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Objective: Superior sulcus tumors with involvement of the spine have historically been considered unresectable.
We have previously documented a 2-year survival of 54% in patients treated with a multimodality approach. This
work builds on our previous experience and examines the long-term outcomes.
Methods: A retrospective review was performed on patients with superior sulcus non–small cell lung cancer tu-
mors with involvement of the vertebral column (n ¼ 39) treated at The University of Texas MD Anderson Cancer
Center from 1990 to 2006. Their clinical and pathologic data were analyzed for short- and long-term outcomes.
Results: Group 1 included 8 (21%) patients with neuroforamen or transverse process involvement, group 2 had
16 (41%) patients with partial vertebrectomy, and group 3 had 15 (38%) patients with total vertebrectomy. There
were 2 (5%) postoperative deaths, and 11 (28%) patients had major complications. Margins were positive in 17
(44%) patients. Recurrence occurred in 23 (59%) patients and was local in 11 (28%) patients, distant in 11
(28%) patients, and both in 1 (3%) patient. Median time to local recurrence was 7 months in patients with positive
margins and has not been reached for patients with negative margins (P¼ .007). Median, 2-year, and 5-year over-
all survival was 18 months, 47%, and 27%, respectively. On multivariate analysis, the only independent predic-
tor of shorter survival was nodal metastases (P ¼ .001; hazard ratio, 6.5; 95% confidence interval, 2.2–19.2).
Conclusion: An aggressive multimodality approach involving surgical resection can be performed with accept-
able morbidity in highly selected patients with superior sulcus tumors and vertebral invasion at a specialized cen-
ter. Encouraging long-term survival can be achieved in patients with negative margins and no lymph node
involvement.
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Superior sulcus tumors are a rare type of tumor that accounts
for less than 5% of all cases of non–small cell lung cancer
(NSCLC).1 They can be challenging to resect because of
their location and involvement of surrounding structures,
such as the brachial plexus, subclavian vessels, and spine.
Invasion of the spine is a poor prognostic factor and is
traditionally considered a contraindication for resection.
Multimodality therapy, including surgical resection with
preoperative or postoperative chemotherapy and radiation,
is now considered optimal management. Because of the
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vertebral involvement, there have been no large studies
that evaluate the optimal treatment algorithm for this highly
selected group of patients. Nevertheless, several small retro-
spective series have demonstrated the feasibility of perform-
ing either partial or total vertebrectomy for select patients
with vertebral invasion, and survival appears to be improved
relative to that seen in historical control subjects.2-7 In 1999,
we reported a series of 17 patients who underwent resection
of superior sulcus tumors that involved the spine.4 Overall 2-
year survival was 54%, but it was 80% in patients with neg-
ative margins. The purpose of this study was to update our
previous experience by analyzing a larger number of patients
and including data on long-term outcome.
MATERIALS AND METHODS
Study Population
The University of Texas MD Anderson Cancer Center Institutional Re-
view Board granted approval for the study. Patients were identified by using
the institutional tumor registry, as well as prospective patient databases
maintained by the Departments of Thoracic and Cardiovascular Surgery
and Neurosurgery. The study period was from January 1, 1990, to Decem-
ber 31, 2006. We defined a superior sulcus tumor as an apical NSCLC with
radiographic, surgical, and/or pathologic involvement of the first rib or first
intercostal space. For inclusion in the study, patients had to have either sur-
gical or pathologic evidence of neuroforamen or vertebral invasion. Preop-
eratively, involvement of the spinal structures and staging of the primary
tumor was evaluated by means of computed tomographic scan or magneticardiovascular Surgery c Volume 137, Number 6 1379
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NSCLC ¼ non–small cell lung cancer
resonance imaging in all patients. Nodal staging was performed with com-
puted tomographic scanning, positron emission tomographic scanning, and
mediastinoscopy (n ¼ 7). Patients with tumors abutting the spine on preop-
erative imaging but found at the time of surgical intervention not to have
vertebral or neuroforaminal invasion were excluded. Collected data in-
cluded demographic information, preoperative imaging studies, clinical
and pathologic staging, preoperative and postoperative therapy, extent of re-
section, margin status, perioperative data, and survival and recurrence infor-
mation.
Fourteen (36%) patients received preoperative chemotherapy, and 14
(36%) received a preoperative radiation median dose of 46 Gy (range, 6–
64 Gy). Twelve (31%) patients received both chemotherapy and radiation
preoperatively. Chemotherapy was platinum based in all cases. Adjuvant
chemotherapy regimens were similar and again all platinum based; how-
ever, higher doses of radiation were generally used (Table 1). Twenty-one
(54%) patients received postoperative radiation, with dose information
available for 16 (median, 60 Gy; range, 30–65 Gy). Eleven (28%) patients
received postoperative platinum-based chemotherapy. Of these, 8 (21%)
received both chemotherapy and radiation.
Surgical Technique
Extent of vertebral resection was classified as follows: group 1, patients
with transverse process or neuroforamen involvement only; group 2, pa-
tients with vertebral body involvement requiring partial resection of one
or more vertebrae; and group 3, patients with vertebral body involvement
requiring complete resection of 1 or more vertebrae. In group 1 the trans-
verse process was drilled out with a high-speed diamond burr power drill.
Involvement of the surrounding posterior osseous elements was ablated
with additional high-speed diamond burr resection. If there was significant
extension of the tumor into the spinal canal or gross invasion of the proximal
transverse process, facet joints, or lamina, a multilevel laminectomy was
performed with a posterior midline extension of the thoracotomy incision.
This allowed visualization of the thecal sac, as well as the ipsilateral nerve
roots involved with the tumor. These roots could then be ligated proximal to
the dorsal root ganglion. Patients in this group did not require spinal stabi-
lization. In group 2 osseous involvement of the vertebral bodies was limited
to the cortical bone, and partial vertebrectomy was performed with a high-
speed diamond burr power drill and various sizes of curettes. The bony mar-
gin could not be assessed at the time of the operation, and therefore the re-
section was continued until, in the opinion of the attending neurosurgeon,
grossly normal bone was visualized. The surrounding soft tissue structures
were sent for frozen section analysis to ensure the tumor was not present at
those margins.
Posterior stabilization was required in only 1 patient in this group. This
patient had all the posterior elements, facet joints, and posterior aspects of
the vertebral bodies at the 2 levels resected and was therefore believed to
be unstable posteriorly. All patients in groups 1 and 2 had their spinal
and lung resections performed as a single operative procedure. In group 3
extensive osseous involvement necessitated complete vertebrectomy. The
decision to perform complete vertebrectomy was generally based on the
amount of vertebral bony involvement demonstrated on preoperative imag-
ing. Patients who had invasion beyond the cortex of the vertebra with sig-
nificant cancellous involvement underwent total vertebrectomy. During
the earlier part of the study, this was performed in the lateral decubitus
position at the same time as lung resection by extending the thoracotomy
incision posteriorly and cephalad to expose the spine. A multilevel laminec-
tomy was performed followed by posterior instrumentation. After disartic-
ulation of the involved ribs and chest wall resection, total vertebrectomy was1380 The Journal of Thoracic and Cardiovascular Superformed with an intralesional approach. The entire bony structure of the
vertebrae was removed with either the high-speed drill or with mechanical
debridement with a curette. Therefore no bony margin was left to analyze for
margin status. The surrounding soft tissue structures were sent for frozen
section analysis to ensure the tumor was not present at those margins.
The vertebrectomy defect was reconstructed with methylmethacrylate by
using the chest tube technique described by Cooper, Errico, and their col-
leagues.8,9 Anterior fixation was obtained with an anterior cervical locking
plate and screw construct. Since 2004, a 2-stage approach was used (n ¼ 2).
Multilevel laminectomy with posterior stabilization is performed first in the
prone position, followed 24 or 48 hours later by thoracotomy and vertebral
body resection. Expandable titanium cages (Figure 1) are used to reconstruct
the vertebral column (n ¼ 2). Surgical approach included cervicoanterior
thoracotomy (Dartevelle technique; n ¼ 2), posterolateral thoracotomy (n
¼ 28), and combined thoracotomy (n ¼ 9). Where possible, we attempt
to preserve the clavicle because its resection can result in severe shoulder
deformity when combined with a posterolateral thoracotomy.10
Statistical Analysis
Statistical analysis was performed with SPSS software (version 15;
SPSS, Inc, Chicago, Ill). Cox regression analysis and the Student’s t, c2,
and Fisher’s exact tests were used where appropriate. Survival was calcu-
lated from the date of surgical intervention until the date of last follow-up
or death. Survival curves were estimated by using the Kaplan–Meier
method with the log-rank analysis for survival comparisons. Local recur-
rence was defined as tumor recurrence within the operative bed, ipsilateral
chest, or mediastinum. Time to recurrence was dated from the date of sur-
gical intervention to first radiographic or pathologic confirmation of recur-
rent tumor.
RESULTS
Patient Characteristics
There were 39 patients, of whom 10 (26%) were women,
and the median age was 56 years (range, 35–75 years). The
most common presenting symptom was shoulder or arm
pain, which was present in 36 (92%) patients. Other present-
ing features included hand weakness in 14 (36%) patients
and Horner’s syndrome in 11 (28%) patients. On preopera-
tive imaging, abutment or involvement of the subclavian ves-
sels was present in 11 (28%) patients, and 27 (69%) patients
had invasion of the brachial plexus (T1 nerve root in 20 pa-
tients and T1 and C8 nerve roots in 7 patients). Patient demo-
graphics and tumor characteristics are summarized in Table 2.
Surgical Treatment
Operations were performed with curative intent in 35
(90%) patients and were palliative, for pain relief, or for
TABLE 1. Preoperative and postoperative chemotherapy regimens
Preoperative Postoperative
Cisplatnin/VP-16 3 Cisplatnin/VP-16 4
Cisplatnin/vinblastine 2 Cisplatnin/vinblastine 1
Cisplatnin/vinorelbine 1 Carboplatnin/taxol 2
Carboplatnin/gemcitabine 1 Carboplatnin/docetaxol 1
Carboplatnin/taxol 7 Adriamycin/Ifosfamide 1
Unknown 2
Summary 14 Summary 11rgery c June 2009
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adjustable titanium cages (Synthes, Inc, West Chester, Pa), which are packed with bone graft.prevention of spinal cord compromise in 4 (10%) patients.
Two (5%) patients underwent resection through a cervicoan-
terior (Dartevelle technique) approach alone, with division
of the manubrium and preservation of the ipsilateral clavicle.
Nine (23%) patients required combined cervicoanterior and
posterolateral thoracotomy, and 28 (72%) patients had pos-
terolateral thoracotomy only. Although the tumor abutted
the subclavian artery in 11 (28%) patients, only 1 patient
required subclavian artery resection. In this patient the sub-
clavian artery was reconstructed with an 8-mm ringed poly-
tetrafluoroethylene graft. The extent of pulmonary resection
was decided based on the size and location of the lesion, and
a wedge resection was performed at the discretion of the at-
tending surgeon. This was based on the pulmonary status of
the patient, the extent of lung involved, and the knowledge
that recurrence typically occurs locally at the site of the ver-
tebral resection or distant rather than within the pulmonary
parenchyma or nodal basins.
Pulmonary resection included lobectomy in 26 (67%)
patients, pneumonectomy in 2 (5%) patients, and wedge
resection in 11 (28%) patients (Table 2). Wedge resections
were equally distributed among all 3 groups in this study.
Chest wall resection of 3 or more ribs was required in 30
(77%) patients. Eight (21%) patients had resection limited
to the neuroforamen (n ¼ 1), transverse process (n ¼ 1),
or both (n ¼ 6; group 1); 16 (41%) patients required partial
vertebrectomy (group 2); and 15 (39%) patients had total
vertebrectomy (group 3). In group 3 the median number of
vertebral levels resected was 2 (Table 2). Three (38%)
patients in group 1, 6 (38%) in group 2, and 8 (53%) in
group 3 had positive surgical margins on final pathology
(P ¼ .70).The Journal of Thoracic and CThe median length of stay was 10.5 days (range, 4–48
days). Major postoperative complications occurred in 11
(28%) patients and included pneumonia (n ¼ 8), respiratory
failure (n ¼ 5), pneumonitis (n ¼ 1), aspiration (n ¼ 1), em-
pyema (n ¼ 1), or death (n ¼ 2). There were 2 (5%) perio-
perative deaths, 1 from herpetic pneumonia in a patient after
pneumonectomy and 2-level vertebrectomy and another
from pneumonia and respiratory failure in a patient who
had lobectomy and partial vertebrectomy.
Pathologic Factors
The median maximal tumor size was 5.9 cm (range, 2–24
cm), and squamous cell carcinoma and adenocarcinoma ac-
counted for 36% and 33% of cases, respectively (Table 2).
Fourteen (36%) patients had lymph node metastases. Of
these, 5 (13%) patients were N1, 6 (15%) were N2, and 3
(8%) had supraclavicular nodes (N3) involved. Complete
resection (R0) was obtained in 22 (56%) patients. Micro-
scopic positive margins (R1) were found on the final patho-
logic specimen in the remaining 16 (41%) patients. One
patient had resection with residual macroscopic tumor re-
maining (R2).
Nonsurgical Therapy
One (6%) patient who received preoperative treatment had
a complete pathologic response. Two (13%) patients had mi-
croscopic residual disease identified at surgical intervention,
and the remaining 13 (81%) patients had gross disease pres-
ent at the time of the operation. Preoperative treatment with
radiation, chemotherapy, or a combination of both did not
have an effect on the completeness of resection (positiveardiovascular Surgery c Volume 137, Number 6 1381
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who received neoadjuvant treatment, adjuvant treatment, or
both.
Survival and Recurrence
Median, 2-year, and 5-year overall survival was 18 months,
47%, and 27%, respectively (Figure 2). There was a
nonsignificant trend toward decreased survival with increas-
ing extent of vertebral resection (Table 3). Nodal metastases
and positive resection margins were associated with worse
survival (Table 3 and Figures 3 and 4). Multivariate analysis
included the following variables: age, sex, tumor size, type
of lung resection, preoperative chemotherapy, preoperative
radiation, postoperative radiation, vertebral resection group,
lymph node status, and margin status. Only lymph node status
independently predicted survival (P¼ .001; hazard ratio, 6.5;
95% confidence interval, 2.2–19.2).
Tumor recurrence occurred in 23 (59%) patients and was
local in 11 (28%) patients, distant in 11 (28%) patients, and
both local and distant in 1 (3%) patient. Extent of vertebrec-
tomy did not influence rates of local or distant failure or time
TABLE 2. Demographics
Factor N
Patients 39
Age, y (median [range]) 56 (35–75)
Sex
Male 29 (74%)
Female 10 (26%)
Histology
Adenocarcinoma 13 (33%)
Squamous 14 (36%)
Large cell 2 (5%)
Other* 10 (26%)
Nodal status
N0 25 (64%)
N1 5 (13%)
N2 6 (15%)
N3 3 (8%)
Type of lung resection
Wedge 11 (28%)
Lobectomy 26 (67%)
Pneumonectomy 2 (5%)
Type of vertebral resection
Transverse process or neuroforamen 8 (21%)
Partial vertebrectomy 16 (41%)
Total vertebrectomy 15 (38%)
No. of vertebrae resected
1 13 (42%)
2 14 (45%)
3 4 (13%)
Margin status
Positive 17 (44%)
Negative 22 (56%)
*Sarcomatoid, poorly differentiated, or non–small cell lung cancer not otherwise
specified.1382 The Journal of Thoracic and Cardiovascular Suto recurrence. Twelve (55%) patients with negative nodes
had recurrence compared with 11 (79%) patients with pos-
itive nodes (P¼ .06). Median time to recurrence was signif-
icantly shorter in patients with positive nodes (5 vs 34
months, P< .01). Patients with positive nodes had a higher
incidence of local recurrence compared with patients with
negative nodes (57% vs 16%, P< .01); however, there
was no difference in the rates of distant failure (29% vs
24%, P ¼ .52). Recurrence was more frequent among pa-
tients with positive surgical margins (76% vs 45%, P ¼
.05), and time to first recurrence was also shorter (6.5 vs
23.9 months, P< .05). Local recurrence rates were higher
in patients with positive margins (53% vs 14%, P< .01),
but there was no difference in the rates of distant failure
(29% vs 32%, P¼ .54). Multivariate analysis for overall re-
currence included the following variables: type of lung
resection, tumor size, preoperative chemotherapy, extent
of vertebrectomy, lymph node status, and margin status.
Only lymph node status independently predicted recurrence
(P ¼ .001; hazard ratio, 6.9; 95% confidence interval, 2.3–
20.9).
DISCUSSION
Superior sulcus tumors were first described by Pancoast11
in 1924, who postulated that the tumor originated from epi-
thelial rests of the fifth branchial cleft. A bronchopulmonary
origin was determined by Tobias12 in 1932. These tumors
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FIGURE 2. Overall survival from date of surgical intervention.
TABLE 3. Survival by group and nodal and margin status
n Median (mo) 2 y 5 y P value
Group 1 8 35.5 63% 38% .31
Group 2 16 24.3 55% 27%
Group 3 15 11.2 29% 22%
Node negative 25 38.7 71% 41% <.001
Node positive 14 7.0 0% 0%
Margin negative 22 38.7 62% 39% <.03
Margin positive 17 13.1 29% 12%rgery c June 2009
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tures that can be difficult to resect, such as the vertebral bod-
ies, brachial plexus, and subclavian vessels. These factors
contributed to the original assumption that superior sulcus
tumors were uniformly fatal. Over the last 2 decades, inno-
vative surgical techniques have been developed that have
allowed more extensive resections for lesions that were pre-
viously believed to be unresectable (ie, subclavian vessels,
brachial plexus, and vertebral bodies).13,14
Several authors have described techniques for resection of
lung cancer with invasion of the spine.2-4,14,15 Our initial re-
port included 17 patients with superior sulcus tumors that
had spinal involvement.4 Of these, 14 (82%) patients had
vertebral body involvement, which required partial verte-
brectomy in 7 (50%) patients and total vertebrectomy in 7
(50%) patients. As with the current series, en bloc resection
was not performed, but rather high-speed diamond burr
drills were used to perform intralesional resection of the in-
volved vertebrae. There was no perioperative mortality;
however, major complications occurred in 42% of patients.
Despite the study sample consisting of a group of patients
with advanced stage (T4) NSCLC, median overall survival
was 25 months, and 2-year survival of patients with micro-
scopically negative margins (n ¼ 11) was 80%. This study
showed that an aggressive surgical strategy that combined
thoracic and neurosurgical techniques could result in better
than expected survival and tumor control in a group of pa-
tients previously considered unresectable.
Our current study builds on our previous experience but
includes larger patient numbers and longer follow-up. In
common with our earlier report, the majority of patients
had vertebral body involvement (79%), and the proportions
of patients undergoing partial and total vertebrectomy
were similar (52% and 48%, respectively). Despite the
fact that positive margins were more frequent in the current
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FIGURE 3. Survival by lymph node status. Solid line, negative nodes;
dashed line, positive nodes.The Journal of Thoracic and Cstudy (44% vs 35%), local failure was slightly less common
(31% vs 41%), and distant failure was more frequent (31%
vs 12%), perhaps related to a longer follow-up period in the
current study. Similar to Gandhi and colleagues,4 we found
that margin status significantly influenced not only local re-
currence but also survival. However, at variance with our
earlier report, we found that nodal metastases were an inde-
pendent predictor of shorter survival. Interestingly, nodal
metastases also were associated with local but not distant
recurrence.
Several studies published in the English-language litera-
ture address surgical management of this specific population
of patients. A series of 42 patients with superior sulcus tu-
mors with spinal or brachial plexus involvement from Me-
morial Sloan Kettering Cancer Center were reported by
Bilsky and associates.15 Of these, vertebral invasion (ante-
rior or posterior elements) was present in only 14 (33%)
patients, with periosteal or neuroforaminal involvement
present in 38% and 29%, respectively. This contrasts with
our current study, in which vertebral body invasion was
present in 31 (79%) patients. Bilsky and associates per-
formed vertebrectomy in a manner similar to our approach
with intralesional resection, and although the exact number
of patients undergoing vertebrectomy was not reported,
overall survival (17 months) was remarkably similar to
that seen in our current study (18 months). Despite more pa-
tients having received neoadjuvant treatment in the Memo-
rial series compared with ours (66% vs 41%) and fewer
patients with vertebral invasion, rates of local recurrence
and survival were almost identical (Table 4).
Another study, by Grunenwald and coworkers,5 reported
19 patients who underwent surgical intervention for lung
cancers that involved the spine. It is important to note that
this study included patients with superior sulcus and non–
superior sulcus tumors. As in our study, the majority of
patients had vertebral invasion (68%); however, the
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FIGURE 4. Survival by margin status. Solid line, Negative margins;
dashed line, positive margin.ardiovascular Surgery c Volume 137, Number 6 1383
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Bilsky et al15 Grunenwald et al5* Current study
No. 42 19 39
Vertebral body invasion 14 (33%) 13 (68%) 31 (79%)
Node positive NR 6 (32%) 14 (36%)
En bloc No Yes No
Partial vertebrectomy NR 15 (79%) 16 (52%)
Total vertebrectomy NR 4 (21%) 15 (48%)
R0/R1 (complete) 27 (64%) 15 (79%) 22 (56%) (R0)
R2 (incomplete) 15 (36%) 4 (21%) 17 (44%) (R1/R2)
Neoadjuvant 28 (66%) 11 (58%) 16 (41%)
Adjuvant 9 (21%) 5 (26%) 24 (62%)
Major complications 14 (33%) 9 (47%) 11 (28%)
Length of stay NR 30 days 10 days
Median survival 17.3 mo 24 mo 18 mo
2-y Survival 44.00% 53% 47%
5-y Survival 26% 14% 27%
Recurrence 20 (48%) 15 (79%) 23 (59%)
Local 16 (38%) 8 (42%)y 12 (31%)z
Distant 4 (10%) 7 (37%) 12 (31%)
*Includes non–superior sulcus tumors. yLocal and distant recurrence in 2 patients. zLocal and distant recurrence in 1 patient.technique of resection was different in that vertebrectomy
was performed by using an en bloc technique rather than
the intralesional approach used in our study. Only 4
(21%) patients underwent total vertebrectomy compared
with 15 (48%) patients in our series. Although median sur-
vival was excellent (24 months), 2-year survival was similar
to that seen in our series (53% vs 47%), but 5-year survival
was slightly inferior (14% vs 27%). Grunenwald and co-
workers5 found that patients with negative margins after sur-
gical intervention had better median and 2-year survival (34
months and 74%, respectively), which is similar to what we
have observed (39 months and 62%, respectively).
A third study, by Fadel and associates,16 looked at en bloc
hemivertebrectomies in 17 patients with superior sulcus lung
cancer. Their study had a higher R0 resection rate than in our
present series (76% vs 56%). However, the recurrence rates
(59% vs 59%) and 5-year survival rates (20% vs 27%)
were similar in both studies.
Despite using what might be thought a more oncologi-
cally sound approach of en bloc resection, rates of local
and distant recurrence were similar between our series and
that of Grunenwald and coworkers (Table 4).5 In addition,
the technique of en bloc vertebrectomy was associated
with a higher incidence of postoperative complications and
longer hospital course than in our study. Furthermore, total
vertebrectomy mandated use of a plastic brace for spine im-
mobilization for up to 3 months postoperatively. Because of
the frequent use of both posterior and anterior spine fixation
and reconstruction of resected vertebral bodies at our institu-
tion, patients do not routinely require an external prosthesis.
In 1956, Chardack and MacCallum17 reported the 5-year
survival of a patient who underwent surgical resection of
a superior sulcus tumor followed by postoperative radiation.1384 The Journal of Thoracic and Cardiovascular SIt was not until 5 years later that Shaw and colleagues18 pub-
lished their experience with preoperative radiation (30–35
Gy) and surgical resection in 18 patients who achieved
good local control (despite no 5-year survivors). This land-
mark study has influenced management of superior sulcus
tumors for more than 40 years. Despite no randomized
data comparing preoperative with postoperative treatment,
neoadjuvant chemoradiation has become the standard of
care.19 Certainly, the encouraging results of Southwest On-
cology Group Trial 9416, which reported 44% 5-year sur-
vival with preoperative cisplatin/etoposide and radiation to
45 Gy, argues in favor of the use of preoperative treatment
for superior sulcus tumors.20 However, whether an induction
approach is appropriate for tumors that invade the spine is
uncertain. The majority of patients in Southwest Oncology
Group Trial 9416 had T3 tumors, and of the 32 (29%)
patients with clinical T4 tumors, only 23 (72%) underwent
resection, most without vertebrectomy. Nineteen (59%)
patients with T4 disease had recurrence, and of these, 9
(28%) had local failure, which is similar to the rate we ob-
served in our study. The only predictive factor for long-
term survival in Southwest Oncology Group Trial 9416
was a complete pathologic response at the time of the oper-
ation, which was achieved in 29% of patients.
Another prospective study of induction therapy with sur-
gery for superior sulcus tumors was the Japan Clinical On-
cology Group trial 9806,21 which reported 5-year survival
of 56%. These investigators found that complete pathologic
response (present in 12 [16%] patients), complete resection,
and T3 tumor stage were associated with long-term survival.
Of importance, only 11 (55%) patients with T4 tumors un-
derwent surgical resection, and of these, only 3 had verte-
brectomy.urgery c June 2009
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sulcus tumors was that by Fischer and associates in 2008.22
Their study had 44 patients who underwent 2 cycles of
cisplatin and etoposide with concurrent 45-Gy radiation.
Mortality in this study was 5%, an R0 resection was
achieved in 89%, and the recurrence rate was 36%. Five-
year survival for the entire group was 59%. For patients
with a complete response to induction therapy, a 5-year sur-
vival of 90%was achieved. For patients with no response to
induction therapy, the 5-year survival was 12%. They con-
cluded that surgical resection after induction therapy was
safe and could be achieved in patients who responded with
good survival. However, this study had only 15 patients
who had a portion of a vertebral body resected. This makes
it difficult to interpret the results from this study when look-
ing at patients who require vertebral body resection.
Although our numbers were small, we did not observe
a difference in survival outcomes between patients receiving
preoperative versus postoperative adjunctive therapy. In
contrast with the studies above, of 16 patients who received
preoperative treatment, only 1 (6%) pathologic complete re-
sponse was seen, and there were only 2 (13%) patients with
microscopic residual tumor after induction treatment. Fur-
thermore, when compared with the reports by Bilsky and as-
sociates15 and Grunenwald and coworkers,5 in which use of
preoperative treatment was favored, survival rates and pat-
terns of recurrence in our study were similar. The data avail-
able therefore do not present a strong argument in favor of
preoperative over postoperative regimens in patients with
superior sulcus tumors with vertebral involvement.
Our philosophy with respect to adjunctive therapies in the
management of these tumors has been in favor of immediate
surgical resection, followed by postoperative radiation and
chemotherapy. The rationale for this approach is as follows.
First, in patients who receive preoperative radiation and who
are subsequently found at the time of surgical intervention
to have positive margins, additional postoperative radiation
therapy is usually not feasible, and local tumor recurrence is
virtually guaranteed. Second, immediate surgical intervention
not only offers quicker and more durable palliation of pain
than chemoradiation but also avoids the risk of tumor progres-
sion in chemotherapy and radiation-insensitive tumors. Third,
there are reliable data regarding the survival benefit of postop-
erative chemotherapy for stage I to III lung cancer, whereas the
data regarding use of preoperative chemotherapy is less con-
vincing. Lastly, administration of high-dose radiation preop-
eratively can complicate surgical resection because of
fibrosis and obliteration of normal tissue planes.
As with all retrospective studies, ours has several limita-
tions. First, the patients in this study represent a group of
patients who were considered to have tumors amenable to
resection and who were physiologically able to withstand
surgical intervention. This group might not be reflective of
the entire population of patients with superior sulcus tumorsThe Journal of Thoracic and Cand vertebral involvement. Second, the treatment period
spanned 20 years, during which preoperative staging, ad-
junctive regimens, and surgical techniques have evolved.
Although all of the resections were performed at a single
institution, adjunctive treatment was often performed else-
where, and this adds to treatment variation and inconsis-
tency. Third, despite the fact that this series represents one
of the largest series of patients with superior sulcus NSCLC
and vertebral invasion, the sample size is still small.
Nevertheless, we believe that certain conclusions can be
drawn from the data presented. We have confirmed the feasi-
bility of concomitant lung and vertebral resection in selected
patients with superior sulcus tumors and vertebral invasion.
Long-term survival is possible and is most likely in patients
who can undergo complete tumor resection and who do not
have nodal disease. For this reason, we recommend routine
preoperative evaluation of mediastinal nodes. Patients found
to have lymph node metastasis preoperatively have a poor
prognosis, and nonsurgical management should be consid-
ered for these patients. We believe that chemotherapy and ra-
diation are important components of the treatment regimen for
these patients, and for reasons discussed above, we favor post-
operative rather than preoperative therapy, although there are
few data to support one approach over the other. Although ret-
rospective and based on small numbers of patients, the avail-
able data do not show a major difference in local recurrence or
survival between en bloc versus intralesional approaches.
Lastly, with the use of a multidisciplinary approach, vertebral
involvement should not necessarily be a contraindication to
resection in patients with superior sulcus tumors, and these pa-
tients deserve surgical consultation before development of
a definitive treatment plan at specialized centers.
References
1. Komaki R, Roth JA, Walsh GL, Putnam JB Jr, Vaporciyan A, Lee JS, et al. Out-
come predictors for 143 patients with superior sulcus tumors treated by multidis-
ciplinary approach at the University of Texas MD Anderson Cancer Center. Int J
Radiat Oncol Biol Phys. 2000;48:347-54.
2. Grunenwald D, Mazel C, Girard P, Berhiot G, Dromer C, Baldeyrou P. Total ver-
tebrectomy of en bloc resection of lung cancer invading the spine. Ann Thorac
Surg. 1996;61:723-6.
3. York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, et al.
Combined chest wall resection with vertebrectomy and spinal reconstruction
for the treatment of Pancoast tumors. J Neurosurg. 1999;91:74-80.
4. Gandhi S, Walsh GL, Komaki R, Gokaslan ZL, Nesbitt JC, Putnam JB, et al. A
multidisciplinary surgical approach to superior sulcus tumors with vertebral inva-
sion. Ann Thorac Surg. 1999;68:1778-84.
5. Grunenwald D, Mazel C, Girard P, Veronesi G, Spaggiari L, Gossot D, et al. Rad-
ical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc
Surg. 2002;123:271-9.
6. Koizumi K, Haraguchi S, Hirata T, Hirai K, Mikami I, Yamagishi S, et al. Surgical
treatment of superior sulcus tumors. Surg Today. 2005;35:357-63.
7. Yokomise H, Gotoh M, Okamoto T, Yamamoto Y, Ishikawa S, Liu D, et al. En
bloc partial vertebrectomy for lung cancer invading the spine after induction che-
moradiotherapy. Eur J Cardiothorac Surg. 2007;31:788-90.
8. Cooper PR, Errico TJ, Martin R, Crawford B, DiBartolo T. A systematic approach
to spinal reconstruction after anterior decompression for neoplastic disease of the
thoracic and lumbar spine. Neurosurgery. 1993;32:1-8.
9. Errico TJ, Cooper PR. A new method of thoracic and lumbar body replacement
for spinal tumors. Neurosurgery. 1993;32:678-81.ardiovascular Surgery c Volume 137, Number 6 1385
General Thoracic Surgery Bolton et al
G
T
S10. de Perrot M, Rampersuad R. Anterior transclavicular approach to malignant tu-
mors of the thoracic inlet: importance of the scapulothoracic articulation. J Thorac
Cardiovasc Surg. 2007;134:801-3.
11. Pancoast HK. Importance of careful roentgen-ray investigations of apical chest
tumors. JAMA. 1924;83:1407-11.
12. Tobias JW. Sindrome apico-costo-vertebral doloroso por tumor apexiano: su valor
diagnostico en el cancer primitvo pulmonary.RevMedLatinoAm. 1932;17:1522-56.
13. Dartevelle PG, Chapelier AR, Macchiarini P, Lenot B, Cerrina J, Ladurie FL, et al.
Anterior transcervical-thoracic approach for radical resection of lung tumors in-
vading the thoracic inlet. J Thorac Cardiovasc Surg. 1993;105:1025-34.
14. DeMeester TR, Albertucci M, Dawason PJ, Montner SM. Management of tumor
adherent to the vertebral column. J Thorac Cardiovasc Surg. 1989;97:373-8.
15. Bilsky MH, Vitaz TW, Boland PJ, Bains MS, Rajaraman V, Rusch VW. Surgical
treatment of superior sulcus tumors with spinal and brachial plexus involvement.
J Neurosurg. 2002;97:301-9.
16. Fadel E, Missenard G, Chapelier A, Mussot S, Leroy-Ladurie F, Cerrina J, et al.
En-Bloc resection of non-small cell lung cancer invading the thoracic inlet and in-
tervetrebal foramina. J Thorac Cardiovasc Surg. 2002;123:676-85.
17. Chardack WM, McCallum JD. Pancoast tumor: five-year survival without recur-
rence or metastases following radical resection and postoperative irradiation.
J Thorac Surg. 1956;31:535-42.
18. Shaw RR, Paulson DL, Kee JL Jr. Treatment of the superior sulcus tumor by
irradiation followed by resection. Ann Surg. 1961;7:29-40.
19. Rusch VW, Parekh KR, Leon L, Venkatranam E, Bains MS, Downey RJ, et al.
Factors determining outcome after surgical resection of T3 and T4 lung cancers
of the superior sulcus. J Thorac Cardiovasc Surg. 2000;119:1147-53.
20. Rusch VW, Giroux DJ, Krault MJ, Crowley J, Hazuka M, Winton T. Induction
chemoradiation and surgical resection for superior sulcus non-small-cell lung car-
cinomas: long term results of Southwest Oncology Group Trial 9416 (Intergroup
Trial 0160). J Clin Oncol. 2007;25:313-8.
21. Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichonose Y, et al. Phase II
trial of preoperative chemoradiotherapy followed by surgical resection in patients
with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncol-
ogy Group Trial 9806. J Clin Oncol. 2008;26:644-9.
22. Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, et al. Induction
chemoradiation therapy followed by surgical resection for non-small cell lung
cancer (NSCLC) invading the thoracic inlet. Eur J Cardiothorac Surg. 2008;
33:1129-34.
Discussion
Dr Marc de Perrot (Toronto, Ontario, Canada). Dr Bolton,
that was a very nice presentation and I would like to congratulate
you and your colleagues from MD Anderson for reporting on this
very challenging group of patients.
Spinal resection for non–small cell lung cancer has now been re-
ported by several groups with good results and is certainly the best
option for a carefully well-selected group of patients.
In Toronto we have done about 25 hemivertebrectomy and
a handful of total vertebrectomy for non–small cell lung cancer in-
volving the spine. Although I don’t want to spend too much time
describing our results, I think it is important to emphasize that
our approach has been different than the one from MD Anderson
in the sense that we have used induction chemoradiation therapy
for all of our patients and have completed the resection en bloc be-
tween the lung and the spine. The approach you have just presented
has been primarily surgery with an intralesional resection of the tu-
mor rather than an en bloc resection, as you mentioned. This differ-
ence probably results from the fact that you have been working with
neurosurgeons, whereas we have been working with orthopedists
primarily. However, I think when comparing the two approaches,
it is important to make sure that you are comparing the same group
of patients.
As you described, there are several types of spinal resections
with different magnitudes of surgery that can be required for tumors1386 The Journal of Thoracic and Cardiovascular Suinvading the spine. Resection of the transverse process or wedge re-
section of the edge of the vertebral body that was mainly presented
in your groups 1 and 2 are less extensive than the hemivertebrec-
tomy or total vertebrectomy that you have included in group 3.
The spinal resection for group 1 and 2 can usually be done through
the same incision as the lung resection and there is usually no need
for any spinal reconstruction. When a hemivertebrectomy or total
vertebrectomy is performed at the level of T1, it requires an anterior
and a posterior approach in order to completely remove the tumor
en bloc with the spine and to achieve adequate reconstruction of the
spine.
In your presentation, you have included patients with involve-
ment of the neuroforamen along with patients who had involve-
ment of the transverse process in the same group. I don’t think
these two groups of patients are similar, at least in our experience.
In our practice, patients with involvement of the neuroforamen
would usually have an en bloc hemivertebrectomy with the lung re-
section in order to be able to section the nerve root inside the spinal
canal and achieve complete resection. This would then be followed
by spinal stabilization. Patients with involvement of the transverse
process otherwise would have resection of the transverse process
with the chest wall resection and would not require any type of spi-
nal stabilization.
So my first question is, how many patients in your first group had
involvement of the neuroforamen versus involvement of the trans-
verse process and how many patients required spinal stabilization
in that specific group of patients?
Dr Bolton. Thank you for your comments and question.
I think that your question is how many patients in group 1, 8 pa-
tients, had neuroforamen involvement by itself or transverse process
by itself. We did not break that group into a smaller group. There
were only 8 of those. So I don’t have the information of which
ones had just neuroforamen involvement. I do know that none of
those patients had to have a spinal stabilization for their resection.
Dr de Perrot. My second question relates to the surgical resec-
tion margins. You mentioned that 44% of your patients had a posi-
tive resection margin, which is higher than what has been reported
in other series. This may be due to the fact that you have included
only patients with superior sulcus tumors. However, considering
that you do not attempt to do an en bloc resection but perform an
intralesional resection, I’m wondering how you could interpret
the surgical margin for patients who did not have en bloc resection.
Dr Bolton. Again, I believe your question is how do we assess
the surgical margin in the operating room during the operation.
With that, on the total vertebrectomies, we assess the margins by
taking the soft tissues around the vertebral body that we have re-
sected, and that can be done at the time of the operation. On patients
with a partial vertebrectomy, obviously we can’t send bone for a fro-
zen section, and so we would use the high-speed drill to drill
through to bone that appeared normal and then take samples of
that and send that for a permanent section. So that’s how we as-
sessed our margins.
Dr de Perrot. So if the final specimen was negative, that was
your negative margin?
Dr Bolton.But that would come back on a final pathologic spec-
imen. We would not have that information during the operation. On
the partial vertebrectomies, we would do it to grossly normal-ap-
pearing bone.rgery c June 2009
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SDr de Perrot. My last question relates to the group of patients
who had total vertebrectomy. You mentioned 15 patients in that
group, which is certainly the largest experience reported in the lit-
erature. Looking more specifically at that group of patients, you re-
ported an R0 resection rate of about 50%, with a local recurrence
rate of about 40%, and a 5-year survival of 22%. Again, I think
this is certainly the most difficult group of patients to manage be-
cause of the morbidity that the tumor by itself will create if it is
not controlled locally and because of the complexity of performing
a surgical resection in these patients. My last question is, among all
15 total vertebrectomies that you have done, were all these patients
treated with a curative intent or were some of them treated to
achieve primarily local control? Along the same line, you men-
tioned that 11 patients had a wedge resection rather than a more for-
mal lobectomy, and I would be interested to know if these 11
patients were more specifically in that group of patients who had
a total vertebrectomy.
Dr Bolton. We did not look at how many patients in the total
vertebrectomy group had a wedge resection versus a lobectomy
versus a pneumonectomy, so I can’t give you that answer.
What was the rest of your question?
Dr de Perrot. I’m just wondering whether all these patients
were operated on with a curative intent or were some of them un-
dergoing surgery rather to achieve local control because of the mor-
bidity of these tumors.
Dr Bolton. Yes, there were 4 patients in our study that we did
a palliative resection on. Again, I don’t know exactly where all 4
of those are. Some of those were in the total vertebrectomy group,
but not all of them.
Dr de Perrot. Thank you.
Dr Bolton. Thank you for your questions.
Dr Frank C. Detterbeck (NewHaven, Conn). How do you pre-
operatively stage the patients, nodal staging?
Dr Bolton. How many were preoperatively staged, is that the
question?
Dr Detterbeck. Well, how do you stage them? Do you do me-
diastinoscopy? Do you do PET? What do you do?
Dr Bolton. This was over a long period of time, and so the op-
timal staging for mediastinal.
Dr Detterbeck. What do you think it should be now, given your
experience?
Dr Bolton. Well, given our experience, with the fact that we
found no patients with a positive node either in stations 1, 2, or 3
that lived more than 23 months, I think that if you’re going to do
surgery for this group of patients, you need to adequately stage
the mediastinum with mediastinoscopy or EBUS. With EBUS
you have the ability to maybe stage more than just the mediastinum
and stage levels 10 and 11 lymph nodes, and so that would be an
additional benefit to use EBUS in this patient population.
DrDetterbeck. The second question has to do with the high rate
of incomplete resection. What do you think we can do to improve
that? Certainly preoperative chemoradiotherapy in Pancoast tumors
in general has resulted in a much higher rate of complete resection.The Journal of Thoracic and CDo you think that that is the answer? The other related question is
selection. What criteria do you have to make you say this patient is
not resectable; there is either too much vertebral body involvement,
there’s involvement of the dura, there’s some other aspect of what
contributes to a positive margin that makes that patient not a good
candidate?
Dr Bolton. Thank you for your question.
Looking at the assessment of whether or not we will be able to
get the patient resected, there have been a couple of studies that
have looked at using preoperative imaging, such as MRI, to sort
of help determine whether or not you could be more successful.
Unfortunately, those studies did not show a difference on any of
their definitions of how much vertebral body involvement was
found preoperatively. I don’t think that we have a good imaging
modality to help us with that. Certainly if you had a patient with
multiple vertebral bodies destroyed by tumor, that would be an
easy patient to say that you could not do it on, but otherwise I
don’t think the imaging available currently can tell us that on the
minor points.
Dr Dominique Grunenwald (Paris, France). I was extremely
anxious to discover the late results of the MDA’s multidisciplinary
approach, since we presented at this meeting here in San Diego in
year 2001 the initial part of our series of en bloc resection for non–
small cell lung cancer attached to the spine. Interestingly, our up-
dated data, despite the difference in our respective approaches,
show similar results now. The differences are in the surgical proce-
dures, as we performed an en bloc resection in all cases. Secondly,
the extent of resection is quite different, because our series includes
a large majority of partial resections, of hemivertebrectomies (28
among 34 patients). Thirdly, the complete resection rate that we
achieved was 90% compared to your 56% of complete resections.
Nevertheless, results in terms of long-term survival, 5-year sur-
vival, are absolutely the same, because we achieved a 24% 5-
year survival now compared to your 27% survival. But we didn’t
include the patients with only a transverse or foraminal involve-
ment. So our results and these comments confirm your conclusions,
Dr Bolton. Congratulations.
Dr Bolton. Thank you very much, sir.
Dr Alain Chapelier (Paris, France). Congratulations on this
impressive series of very difficult patients requiring demanding sur-
gical strategies. I have a comment and a short question. Earlier this
year, Philippe Dartevelle and colleagues reported the long-term re-
sults of surgery of superior sulcus tumors with 28% 5-year survival
in the group of patients with en bloc resection, partial vertebrec-
tomy. However, this tumor was only extending into the intraforami-
nal process. So my question is, considering the poor survival of the
subset of patients with positive margins, wouldn’t you be reluctant
to consider such extended surgery if you don’t have a strong prob-
ability of achieving a complete resection?
Dr Bolton. Thank you for your question.
Looking at our data, I would say that it would be much better to
be able to get a negative margin on your resection. So, yes, we
would much prefer to be able to get a negative margin.ardiovascular Surgery c Volume 137, Number 6 1387
